Lineage Cell Therapeutics (LCTX) Operating Margin (2010 - 2026)
Lineage Cell Therapeutics (LCTX) operating margin from Jun 30, 2010 to Mar 31, 2026. The current Lineage Cell Therapeutics (LCTX) operating margin is -438.73%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Lineage Cell Therapeutics (LCTX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -251.51% | +11.24% |
| 2024 | -226.11% | -18.17% |
| 2023 | -276.31% | +80.36% |
| 2022 | -153.20% | -12.46% |
| 2022 | -175.00% | +88.24% |
| 2022 | -92.97% | -23.88% |
| 2022 | -122.14% | -89.23% |
| 2021 | -1133.87% | +276.30% |
| 2021 | -301.32% | -78.29% |
| 2021 | -1388.24% | -23.20% |
| 2021 | -1807.69% | +25.07% |
| 2020 | -1445.36% | +22.60% |
| 2020 | -1178.95% | -28.16% |
| 2020 | -1641.03% | +12.49% |
| 2020 | -1458.82% | +32.07% |
| 2019 | -1104.55% | -25.23% |
| 2019 | -1477.19% | +6.49% |
| 2019 | -1387.18% | +1.10% |
| 2019 | -1372.04% | +63.83% |
| 2018 | -837.47% | -20.78% |
| 2018 | -1057.14% | +194.94% |
| 2018 | -358.43% | -79.42% |
| 2018 | -1741.43% | +54.89% |
| 2017 | -1124.28% | +93.88% |
| 2017 | -579.88% | -74.26% |
| 2017 | -2252.63% | -33.98% |
| 2017 | -3412.12% | +242.54% |
| 2016 | -996.11% | +50.20% |
| 2016 | -663.19% | -46.12% |
| 2016 | -1230.77% | -4.17% |
| 2016 | -1284.32% | +37.39% |
| 2015 | -934.80% | +2.23% |
| 2015 | -914.44% | +18.54% |
| 2015 | -771.43% | -42.86% |
| 2015 | -1350.00% | +39.58% |
| 2014 | -967.18% | -23.52% |
| 2014 | -1264.58% | -16.73% |
| 2014 | -1518.60% | +28.14% |
| 2014 | -1185.11% | -6.23% |
| 2013 | -1263.88% | -36.81% |
| 2013 | -2000.00% | +156.16% |
| 2013 | -780.77% | -59.94% |
| 2013 | -1948.84% | +205.58% |
| 2012 | -637.76% | -11.04% |
| 2012 | -716.87% | +12.01% |
| 2012 | -640.00% | -31.89% |
| 2012 | -939.68% | +122.73% |
| 2011 | -421.90% | +13.70% |
| 2011 | -371.05% | -43.37% |
| 2011 | -655.26% | +33.33% |
| 2011 | -491.46% | +85.11% |
| 2010 | -265.50% | +45.57% |
| 2009 | -182.38% | N/A |
Comparison Lineage Cell Therapeutics (LCTX) operating margin with competitors
Lineage Cell Therapeutics (LCTX) operating margin is -438.73%.